Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107068945> ?p ?o ?g. }
- W2107068945 endingPage "2176" @default.
- W2107068945 startingPage "2169" @default.
- W2107068945 abstract "Both rosiglitazone and metformin increase hepatic insulin sensitivity, but their mechanism of action has not been compared in humans. The objective of this study was to compare the effects of rosiglitazone and metformin treatment on liver fat content, hepatic insulin sensitivity, insulin clearance, and gene expression in adipose tissue and serum adiponectin concentrations in type 2 diabetes. A total of 20 drug-naive patients with type 2 diabetes (age 48 ± 3 years, fasting plasma glucose 152 ± 9 mg/dl, BMI 30.6 ± 0.8 kg/m2) were treated in a double-blind randomized fashion with either 8 mg rosiglitazone or 2 g metformin for 16 weeks. Both drugs similarly decreased HbA1c, insulin, and free fatty acid concentrations. Body weight decreased in the metformin (84 ± 4 vs. 82 ± 4 kg, P < 0.05) but not the rosiglitazone group. Liver fat (proton spectroscopy) was decreased with rosiglitazone by 51% (15 ± 3 vs. 7 ± 1%, 0 vs. 16 weeks, P = 0.003) but not by metformin (13 ± 3 to 14 ± 3%, NS). Rosiglitazone (16 ± 2 vs. 20 ± 1 ml · kg−1 · min−1, P = 0.02) but not metformin increased insulin clearance by 20%. Hepatic insulin sensitivity in the basal state increased similarly in both groups. Insulin-stimulated glucose uptake increased significantly with rosiglitazone but not with metformin. Serum adiponectin concentrations increased by 123% with rosiglitazone but remained unchanged during metformin treatment. The decrease of serum adiponectin concentrations correlated with the decrease in liver fat (r = −0.74, P < 0.001). Rosiglitazone but not metformin significantly increased expression of peroxisome proliferator–activated receptor-γ, adiponectin, and lipoprotein lipase in adipose tissue. In conclusion, rosiglitazone but not metformin decreases liver fat and increases insulin clearance. The decrease in liver fat by rosiglitazone is associated with an increase in serum adiponectin concentrations. Both agents increase hepatic insulin sensitivity, but only rosiglitazone increases peripheral glucose uptake." @default.
- W2107068945 created "2016-06-24" @default.
- W2107068945 creator A5006898956 @default.
- W2107068945 creator A5019553315 @default.
- W2107068945 creator A5028953583 @default.
- W2107068945 creator A5039418401 @default.
- W2107068945 creator A5050209565 @default.
- W2107068945 creator A5065650336 @default.
- W2107068945 date "2004-08-01" @default.
- W2107068945 modified "2023-10-18" @default.
- W2107068945 title "Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insulin Resistance, Insulin Clearance, and Gene Expression in Adipose Tissue in Patients With Type 2 Diabetes" @default.
- W2107068945 cites W1530129189 @default.
- W2107068945 cites W1556459089 @default.
- W2107068945 cites W1587875569 @default.
- W2107068945 cites W1985627033 @default.
- W2107068945 cites W1986131332 @default.
- W2107068945 cites W1991688216 @default.
- W2107068945 cites W1995481669 @default.
- W2107068945 cites W1996641308 @default.
- W2107068945 cites W2003323316 @default.
- W2107068945 cites W2007186002 @default.
- W2107068945 cites W2011246715 @default.
- W2107068945 cites W2012492644 @default.
- W2107068945 cites W2019113684 @default.
- W2107068945 cites W2031773477 @default.
- W2107068945 cites W2039211694 @default.
- W2107068945 cites W2046562480 @default.
- W2107068945 cites W2054115426 @default.
- W2107068945 cites W2062560800 @default.
- W2107068945 cites W2078176020 @default.
- W2107068945 cites W2078535741 @default.
- W2107068945 cites W2084672746 @default.
- W2107068945 cites W2088407989 @default.
- W2107068945 cites W2089235913 @default.
- W2107068945 cites W2100514340 @default.
- W2107068945 cites W2105912552 @default.
- W2107068945 cites W2108916652 @default.
- W2107068945 cites W2118723490 @default.
- W2107068945 cites W2126521413 @default.
- W2107068945 cites W2126897591 @default.
- W2107068945 cites W2127934772 @default.
- W2107068945 cites W2132477505 @default.
- W2107068945 cites W2133795831 @default.
- W2107068945 cites W2138226825 @default.
- W2107068945 cites W2141041519 @default.
- W2107068945 cites W2141065273 @default.
- W2107068945 cites W2142504521 @default.
- W2107068945 cites W2147284001 @default.
- W2107068945 cites W2148877387 @default.
- W2107068945 cites W2149703192 @default.
- W2107068945 cites W2157115138 @default.
- W2107068945 cites W2160642543 @default.
- W2107068945 cites W2165391345 @default.
- W2107068945 cites W2315982688 @default.
- W2107068945 cites W2319607702 @default.
- W2107068945 cites W2320006945 @default.
- W2107068945 cites W2412229990 @default.
- W2107068945 cites W2467022164 @default.
- W2107068945 doi "https://doi.org/10.2337/diabetes.53.8.2169" @default.
- W2107068945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15277403" @default.
- W2107068945 hasPublicationYear "2004" @default.
- W2107068945 type Work @default.
- W2107068945 sameAs 2107068945 @default.
- W2107068945 citedByCount "502" @default.
- W2107068945 countsByYear W21070689452012 @default.
- W2107068945 countsByYear W21070689452013 @default.
- W2107068945 countsByYear W21070689452014 @default.
- W2107068945 countsByYear W21070689452015 @default.
- W2107068945 countsByYear W21070689452016 @default.
- W2107068945 countsByYear W21070689452017 @default.
- W2107068945 countsByYear W21070689452018 @default.
- W2107068945 countsByYear W21070689452019 @default.
- W2107068945 countsByYear W21070689452020 @default.
- W2107068945 countsByYear W21070689452021 @default.
- W2107068945 countsByYear W21070689452022 @default.
- W2107068945 countsByYear W21070689452023 @default.
- W2107068945 crossrefType "journal-article" @default.
- W2107068945 hasAuthorship W2107068945A5006898956 @default.
- W2107068945 hasAuthorship W2107068945A5019553315 @default.
- W2107068945 hasAuthorship W2107068945A5028953583 @default.
- W2107068945 hasAuthorship W2107068945A5039418401 @default.
- W2107068945 hasAuthorship W2107068945A5050209565 @default.
- W2107068945 hasAuthorship W2107068945A5065650336 @default.
- W2107068945 hasBestOaLocation W21070689451 @default.
- W2107068945 hasConcept C126322002 @default.
- W2107068945 hasConcept C134018914 @default.
- W2107068945 hasConcept C171089720 @default.
- W2107068945 hasConcept C2776782570 @default.
- W2107068945 hasConcept C2777180221 @default.
- W2107068945 hasConcept C2777391703 @default.
- W2107068945 hasConcept C2779306644 @default.
- W2107068945 hasConcept C2780152017 @default.
- W2107068945 hasConcept C2780323712 @default.
- W2107068945 hasConcept C555293320 @default.
- W2107068945 hasConcept C71924100 @default.
- W2107068945 hasConceptScore W2107068945C126322002 @default.
- W2107068945 hasConceptScore W2107068945C134018914 @default.
- W2107068945 hasConceptScore W2107068945C171089720 @default.